Abstract
Higher hematocrit and serum erythropoietin (EPO) levels have previously been shown in end-stage renal disease patients treated with continuous ambulatory peritoneal dialysis (CAPD) compared with hemodialysis. We investigated whether EPO was produced intraperitoneally in CAPD patients. EPO concentration was 3.5±0.3 mU/ml by radioimmunoassay in 26 samples of peritoneal dialysis effluent obtained from 15 CAPD patients. EPO was not detectable in the fresh unused dialysate. No correlation was observed between EPO levels in the serum and dialysis effluent. Peritoneal macrophages were isolated from the dialysis effluent of 9 CAPD patients after an overnight dwell. The culture supernatant obtained after 24 h of in vitro culture of a million cells yielded EPO of 3.5±0.3 mU/ml. Our study demonstrated that peritoneal macrophages from CAPD patients produce EPO on in vitro stimulation, and EPO is present in the dialysis effluent of CAPD patients.
Similar content being viewed by others
References
Chandra M, Clemons GK, McVicar M, Wilkes B, Bluestone PA, Mailloux LU, Mossey RT (1988) Serum erythropoietin levels and hematocrit in end-stage renal disease: influence of the mode of dialysis. Am J Kidney Dis 12: 208–213
Zappacosta AR, Caro J, Erslev A (1982) Normalization of hematocrit in patients with end stage renal disease on continuous ambulatory peritoneal dialysis. Am J Med 72: 53–57
Chandra M, McVicar M, Clemons G, Mossey RT, Wilkes BM (1987) Role of erythropoietin in the reversal of anemia of renal failure with continuous ambulatory peritoneal dialysis: a case report. Nephron 46: 312–315
Rich IN, Kubanels B (1982) Release of erythropoietin from macrophages mediated by phagocytosis of crystalline silica. J Reticuloendothelial Soc 31: 17–30
Rich IN (1986) A role for the macrophage in normal haemopoiesis. II. Effect of varying physiological oxygen tensions on the release of haemopoietic growth factors from bone marrow derived macrophages in vitro. Exp Hematol 14: 746–751
Garcia JF, Ebbe SN, Hollander L, Cutting HO, Miller ME, Cronkite EP (1982) Radioimmunoassay of erythropoietin: circulating levels in normal and polycythemic human beings. J Lab Clin Med 99: 624–635
Wideroe TE, Sonengen T, Halvorsen S (1983) Erythropoietin and uremic toxicity during continuous ambulatory peritoneal dialysis Kidney Int 24 [Suppl 16]: 208–218
MacDougall IC, Roberts DE, Neubert P, Dharamasana AD, Coles GA, Williams JD (1989) Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Lancet I: 425–427
Kromer G, Solf A, Ehmer B, Kaufman B, Quellhorst E (1990) Single dose pharmacokinetics of recombinant human erythropoietin comparing intravenous, subcutaneous and intraperitoneal administration in IPD patients. Kidney Int 37: 331A
Goldstein CS, Bomalaski JS, Zurier RB, Neilsen EG, Douglas SD (1984) Arlalysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis. Kidney Int 26: 733
Davies SJ, Suassuna J, Ogg CS, Cameron JS (1989) Activation of immunocompetent cell in the peritoneum of patients treated with CAPD. Kidney Int 36: 661–668
Cichocki T, Hanicki Z, Sulowicz W, Smolenski O, Kopec J, Zembala M (1983) Output of peritoneal cells into peritoneal dialysate. Cytochemical and functional studies. Nephron 35: 175–182
Topley N, Alobaidi Haifa MM, Davies M, Coles GA, Williams JD, Lloyd D (1988) The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 34: 404–411
Boelaert JR, Schurgers ML, Matthys EG, Belpaire FM, Daneels RF, De Cre MJ, Bogaert MG (1989) Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous and intraperitoneal routes in continuous ambulatory peritoneal dialysis patients (CAPD). Perit Dial Int 9: 95–98
Flessner MF (1991) Peritoneal transport physiology: insights from basic research. J Am Soc Nephrol 2: 122–135
Regoeczi E, Zaimi O, Chindemi PA, Charlwood PA (1989) Absorption of plasma proteins from peritoneal cavity of normal rats. Am J Physiol 256: E447-E452
Bos HJ, Meyer F, De Veld JC, Beelen RHJ (1989) Peritoneal dialysis fluid induces change of mononuclear phagocyte proportions. Kidney Int 36: 20–26
Dobbie JW (1990) New concepts in molecular biology and ultrastructural pathology of the peritoneum: their significance for peritoneal dialysis. Am J Kidney Dis 15: 97–109
DiPaolo N, Sacchi G (1989) Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD). An in vitro model for the study of diabetic microangiopathy. Perit Dial Int 9: 41–45
Chandra M, McVicar M, Clemons G (1988) Evidence for intraperitoneal production of erythropoietin. Pediatr Res 23: 542A
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chandra, M., Clemons, G., Sahdev, I. et al. Intraperitoneal production of erythropoietin with continuous ambulatory peritoneal dialysis. Pediatr Nephrol 7, 281–283 (1993). https://doi.org/10.1007/BF00853222
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00853222